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Abstract The background and purpose of this paper is to
investigate adherence, exercise performance levels and
associated factors in head and neck cancer (HNC) patients
participating in a guided home-based prophylactic exercise
program during and after treatment [swallowing sparing
intensity modulated radiation therapy (SW-IMRT)]. Fifty
patients were included in the study. Adherence was defined
as the percentage of patients who kept up exercising;
exercise performance level was categorized as low: B1,
moderate: 1–2, and high: C2 time(s) per day, on average.
Associations between 6- and 12-week exercise
performance levels and age, gender, tumour site and stage,
treatment, intervention format (online or booklet), number
of coaching sessions, and baseline HNC symptoms
(EORTC-QLQ-H&N35) were investigated. Adherence rate
at 6 weeks was 70% and decreased to 38% at 12 weeks. In
addition, exercise performance levels decreased over time
(during 6 weeks: 34% moderate and 26% high; during
12 weeks: 28% moderate and 18% high). The addition of
chemotherapy to SW-IMRT [(C)SW-IMRT] significantly
deteriorated exercise performance level. Adherence to a
guided home-based prophylactic exercise program was
high during (C)SW-IMRT, but dropped afterwards. Exer-
cise performance level was negatively affected by
chemotherapy in combination with SW-IMRT.
Keywords Head and neck cancer  (Chemo)radiation 
Prophylactic exercises  Swallowing problems  Speech
problems
Introduction
Intensity modulated radiation therapy (IMRT) targeting
head and neck cancer (HNC) patients allows for more
conformal dose distribution, aiming to minimize the dose
to the surrounding healthy tissues and to spare normal
structures (i.e. the parotid glands). Treatment with IMRT
has proven to lead to less treatment-related side-effects,
such as xerostomia, and to improved health-related quality
of life (HRQOL) [1–12]. Attempts are made to also spare
other organs at risk (OARs), such as the submandibular
glands [13], and the swallowing structures [14]. Van der
Laan et al. [1, 14] demonstrated that, compared with the
standard IMRT, reduction of the dose to the swallowing
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OARs (SWOARs) has the potential to reduce the risk on
swallowing problems through swallowing sparing IMRT
(SW-IMRT). It is hypothesized that patients should be
encouraged to maintain oral intake and to perform exer-
cises to promote the use of the muscles in the head and
neck area. The ongoing use of the swallowing, speech, and
shoulder mechanisms during and after treatment may
enhance the potential benefits of SW-IMRT [15, 16].
Therefore, we developed a guided home-based prophy-
lactic exercise program ‘Head Matters’ to maintain muscle
structure and swallowing, speech, and shoulder function
(HM) [17]. Offering HNC patients such a prophylactic
exercise program may delay the decline of lean muscle
mass in the head and neck area, and may limit the extent of
post-treatment impairment [15, 18–29], eventually leading
to improved HRQOL [15, 16, 21–27, 30]. The current lit-
erature on prophylactic exercise programs varies consid-
erably in terms of timing, intensity, duration, frequency,
and type of exercise. In addition, a broad range (13–71%)
of adherence rates has been reported [17, 21, 25, 31–33].
However, information on patient’s adherence to home-
based exercise programs, on data collected related to daily
exercise performance, and on factors that could potentially
influence patient’s exercise performance is lacking. How
realistic an approach is regarding home-based exercise
programs in HNC patients during SW-IMRT is unknown.
Therefore, the purpose of this study was (1) to investigate
adherence to a 12-week home-based exercise program
during SW-IMRT, (2) to investigate exercise performance
levels, (3) to investigate whether demographic and clinical
factors, or HNC-specific HRQOL at baseline is associated
with exercise performance levels, and (4) to investigate
whether exercise performance levels are associated with




A prospective clinical cohort study.
Patients
Between 2011 and 2013, HNC patients were included in
this study if they were planned for SW-IMRT at VU
University Medical Center (VUmc), Amsterdam, The
Netherlands. Patients fulfilled the following criteria: (1)
age C 18 years, (2) cancer originating in the oral cavity,
oropharynx, hypopharynx, or larynx, (3) SW-IMRT alone
or in combination with chemotherapy [(C)SW-IMRT], (4)
performance status 0–2 on the World Health Organization
Scale [34], (5) the absence of severe cognitive impairment,
and (6) sufficient mastery of the Dutch language (criteria
4–6 as judged by the radiation oncologist who included the
patients in this study). Patients who previously underwent
surgery, radiotherapy, or chemoradiation, who had prior
malignancies in the head and neck area, and/or distant
metastases were excluded. Patients with physician-rated
RTOG grade 2–4 swallowing dysfunction at baseline
(1 = mild fibrosis, slight difficulty in swallowing solids, no
pain in swallowing; 2 = unable to take solid food nor-
mally, swallowing semi-solid food; 3 = severe fibrosis,
able to swallow only liquids, may have pain in swallowing;
4 = necrosis, complete obstruction) (according to the
RTOG/EORTC Late Radiation Morbidity Scoring Schema
[35]) were also excluded to ensure that the observed
swallowing dysfunction was induced by radiation treatment
itself and not by tumour extension.
Patients were treated with curative intent using (C)SW-
IMRT. In all patients, parotid glands and swallowing
structures were spared when possible, without compro-
mising the dose to the target volumes. A simultaneous
integrated boost technique was used with bilateral elective
irradiation of the neck nodes to a total dose of 57.75 Gy,
using a dose per fraction of 1.65 Gy. The primary tumour
and pathological lymph nodes were treated to a total dose
of 70 Gy, in fractions of 2 Gy. Chemotherapy was given
concurrently with radiotherapy and consisted generally of
cisplatin 100 mg/m2 intravenously on days 1, 22, and 43.
The study was approved by the ethical committee of the
VU University Medical Center Amsterdam. Written
informed consent was obtained from all participating
patients.
Intervention
The guided home-based exercise program Head Matters
(HM) was developed by speech and swallowing therapists,
physiotherapists, head and neck surgeons, and radiation
oncologists. HM was based on the previous research
[15, 16, 19–30] and on clinical practice. HNC patients were
recommended to perform HM exercises for at least 15 min
per day in total. HM is comprised of the following pro-
phylactic exercises: (1) exercises to maintain mobility of
the head, neck, and shoulders (e.g., ‘Moving shoulders up
and down’, ‘Circling shoulders forward and backward’)
(‘Shoulder’), (2) exercises to optimize and maintain swal-
lowing function (e.g., ‘Swallowing with strength: effortful
swallow’, ‘Taking sips of water regularly’ (‘Swallow’), (3)
exercises to optimize and maintain vocal health and vocal
function (e.g., ‘Humming with gradually increased volume,
and with exaggerated jaw movement’, ‘Slide up the pitch
scale as high as possible’ (Falsetto exercise) (‘Voice’), and
(4) exercises to optimize and maintain speech function and
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functional communication (e.g., ‘Articulate each syllable’,
‘Stretching the tongue out straight’(‘Speech’). HM informs
the patient on possible swallowing, speech, and shoulder
problems during treatment, and encourages patients to
perform exercises to maintain function [17]. Based on our
clinical experience and earlier study [17], we encourage
patients to exercise at least once a day for 15 min and
preferably three times a day. HM is available in two dif-
ferent formats: (a) online [36] with a description of the
exercises, and with photo and video examples of the
exercises, (b) a 28-page booklet, with the same information
as the online version, photo examples of the exercises, and
a 15-min instructional DVD with video examples of the
exercises. Patients can choose the format that fits their
needs best.
Before patients carry out HM at home, a 15-min face-to-
face instruction session with expert speech and swallowing
therapist’s demonstration of the exercises is planned on the
first day of (C)SW-IMRT. During the course, each patient
is contacted by phone in a weekly 10-min coaching session
by an experienced speech therapist. Patients are asked to
fill out a diary on paper or online for 12 weeks. In their
diaries, patients note which exercises (of the four exercise
categories) they performed, and the frequency of exercising
(1, 2, or 3 times per day).
Measures
A study specific survey was composed comprising items on
sociodemographic data (age, gender, HM format, and
number of coaching sessions) and on HNC-specific
HRQOL (EORTC-QLQ-H&N35) [37]. This survey was
assessed at baseline (T0), every week from the 1st till the
6th week of treatment with (C)SW-IMRT (T1-T6), and
6 weeks after the end of treatment (T12). Clinical data
(tumour site, tumour stage, and treatment modality) were
abstracted from the hospital information system.
Adherence and exercise performance levels
Adherence concerned the percentage of patients who star-
ted and kept up with the HM exercise program at least once
a day across the 6-week period during treatment with
(C)SW-IMRT and across the 12-week period during and
after treatment with (C)SW-IMRT. Adherence was asses-
sed using patient-completed diaries. Non-adherence was
defined as failure to perform any of the exercises. To gain
insight into which exercises were performed most often,
patient’s diaries were analyzed in more detail regarding the
frequency of exercising, exercise performance levels per
week during 6 weeks while undergoing treatment, and
during 12 weeks during and after treatment. Exercise per-
formance was based on patient diaries and consisted of
low-, moderate-, and high-performance levels during 6 and
12 weeks, respectively: (1) low, indicating an exercise
performance of all exercise categories at most once a day
on average (range 1–168; range 1–336), (2) moderate,
indicating an exercise performance of all categories
between once and twice a day on average (range 169–336;
range 337–672), and (3) high, indicating an exercise per-
formance of all exercise categories at least twice a day on
average (range 337–504; range 673–1008). To gain insight
into which exercise category was performed most often, the
diaries were analyzed in detail regarding the exercise fre-
quency per day on average (1–3 times), the exercise fre-
quency per week (the total number of exercise performed
per week ranged from 0 to 84 (4 exercise categories 3 times
per day for 7 days), and type of exercise (‘Shoulder’,
‘Swallow’, ‘Voice’, and ‘Speech’).
Factors associated with exercise performance level
Data were collected on gender, age, tumour site (oral
cavity, oropharynx, hypopharynx, larynx), tumour stage (I,
II, III, IV), treatment modality (SW-IMRT or CSW-
IMRT), intervention format (online or booklet), coaching
(number of sessions), and on HNC-specific HRQOL
(EORTC-QLQ-H&N35).
Statistical analysis
Descriptive statistics were used to summarize adherence,
exercise performance levels, number of coaching sessions,
demographic and clinical characteristics, and HNC-specific
HRQOL (EORTC-QLQ-H&N35). A Chi-square test was
used to examine differences in exercise performance level
at 6 and 12 weeks (low vs moderate/high), regarding
gender (male vs female), tumour site (oral cavity/
oropharynx vs hypopharynx/larynx), tumour stage (stage
I/II vs stage III/IV), treatment modality (RT vs CRT), and
intervention format (online vs booklet). Fisher’s exact tests
were used when the assumption of the expected value of
each cell of 5 or higher was not met. Independent samples
t tests were used to investigate differences in exercise
performance level at 6 and 12 weeks (low vs moderate/
high) regarding age, and Mann–Whitney U tests regarding
the number of coaching sessions (at 6 or 12 weeks), and
HNC-specific HRQOL at baseline (EORTC-QLQ-
H&N35). Longitudinal analysis was performed by gener-
alized estimating equations (GEEs) (jointly testing the
bivariate effect of variables and its time dependence) with
a logit link function and autoregressive correlation matrix
of the first order [AR(1)]. Longitudinal changes in exercise
performance level (low vs moderate/high) per week in
relation to each of the symptom subscales of the EORTC-
QLQ-H&N35 were analyzed. HNC-specific HRQOL was
Eur Arch Otorhinolaryngol (2017) 274:1129–1138 1131
123
measured weekly from baseline through week 6, and at the
end of week 12. The model included both the current value
of the symptom subscales as well as the lagged value (i.e.
the value of the symptom subscale at the previous assess-
ment) of the symptom subscale. Confounding factors (e.g.,
number of coaching sessions) were added as fixed effects
in the model. Data were analyzed using IBM SPSS
Statistics for Windows, version 22. For all analyses,
p\ 0.05 was considered statistically significant.
Results
Participants
Ninety-seven patients were eligible during the study
period. Thirty-seven patients did not participate (38%).
Of these 37 patients, 19 were not willing to participate,
12 refused to fill out any questionnaires, and 6 declared
to be too tired. Of 60 patients who performed the
exercises, 10 diaries were not available, leaving a study
sample of 50 patients. Table 1 shows the demographic,
tumour, and treatment characteristics of the study
population.
Adherence
Table 2 shows that of 50 patients, 35 patients started and
kept up exercising across the first 6 weeks (6-week
adherence rate of 70% and 19 patients kept up exercising
up to 12 weeks (12-week adherence rate of 38%).
Exercise performance level
Table 2 presents the 12-week exercise performance levels,
and exercise performance levels per week of all 50 indi-
vidual patients.
Of all 50 patients, 20 patients (40%) had a low 6-week
exercise performance level, 17 (34%) had a moderate, and
13 (26%) had a high exercise performance level.
Of all 50 patients, 27 patients (54%) had a low 12-week
exercise performance level, 14 (28%) had a moderate, and
9 (18%) had a high exercise performance level).
Figure 1 presents the weekly exercise performance by
exercise category. At the 6th and the 12th week, respec-
tively, patients most often (484 and 348 times) performed
the exercises to maintain mobility of the head, neck, and
shoulders, and the exercises and strategies to optimize, and
to maintain swallowing function: 477 and 336 times.
Factors related to exercise performance levels
Table 3 shows the 6- and 12-week exercise performance
levels in relation to demographic (age, gender) and clinical
factors (tumour site, tumour stage, and treatment modality),
HM intervention format, and to the median number of
coaching sessions. Significantly, more patients treated with
chemotherapy (CSW-IMRT) had a low exercise perfor-
mance level over the first 6 weeks compared with patients
who were treated with SW-IMRT alone, v2(1,
N = 50) = 5.92, p = 0.15 as well as over the entire
12 weeks, v2(1, N = 50) = 13.36, p\ 0.001. Exercise
performance levels during 6 and 12 weeks were not sig-
nificantly associated with age, gender, tumour site, tumour
stage, HM intervention format, or number of coaching
sessions. HNC-specific HRQOL at baseline was not asso-
ciated with exercise performance level during or after
treatment (Table 4). Changes in exercise performance
levels per week in relation to the value of the EORTC-
QLQ-H&N35 subscales in the previous week were ana-
lyzed, using generalized estimating equations (GEEs).
Exercise performance level was significantly related to the
symptom item ‘Problems with mouth opening’: experi-
encing more problems with mouth opening in the previous
week yielded lower odds for a moderate-to-high exercise
performance level in the next week [OR (95% CI) = 0.91
(0.84–0.99), p = 0.037 (Table 5)]. This means that the
more problems a patient experiences with opening his
Table 1 Demographic and clinical characteristics (n = 50)
Age





















Median (range) 9 (4–12)
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Table 2 Participant’s weekly and 12-week exercise performance levels (n = 50)
Patient
number




1 2 3 4 5 6 7 8 9 10 11 12 Low (1–336)
73 ONLINE 0 0 0 4 0 0 0 0 0 0 0 0 4
9 ONLINE 0 0 8 0 0 0 0 0 0 0 0 0 8
74 ONLINE 0 0 0 0 12 0 0 0 0 0 0 0 12
106 BOOK 0 12 0 0 0 0 0 0 0 0 0 0 12
76 BOOK 15 0 0 0 0 0 0 0 0 0 0 0 15
132 ONLINE 0 0 8 4 4 0 0 0 0 0 0 0 16
44 BOOK 0 0 11 11 9 5 7 6 5 6 7 6 73
69 BOOK 12 23 24 16 0 0 0 0 0 0 0 0 75
154 ONLINE 16 14 25 21 6 7 0 0 0 0 0 0 89
150 ONLINE 0 8 4 12 8 0 16 16 12 16 4 0 96
40 ONLINE 0 0 0 29 21 3 15 17 15 12 0 0 112
183 BOOK 34 7 10 8 7 7 7 7 7 7 7 7 115
155 BOOK 12 12 6 11 12 12 13 11 12 11 11 9 132
109 ONLINE 44 12 0 0 0 0 0 0 0 0 40 56 152
96 BOOK 3 8 9 1 32 31 4 17 20 15 18 19 177
151 BOOK 8 28 16 17 14 14 14 15 18 18 18 14 194
80 BOOK 28 36 40 12 4 8 4 16 24 12 20 16 220
38 ONLINE 24 40 48 44 48 40 0 0 0 0 24 0 268
149 BOOK 40 47 28 48 36 28 0 0 28 0 12 4 271
137 BOOK 16 28 29 25 26 30 17 34 30 28 23 0 286
95 BOOK 18 24 26 18 28 19 24 24 28 24 25 28 286
78 BOOK 29 39 36 32 28 32 25 1 4 10 28 28 292
55 ONLINE 12 63 48 51 20 20 12 8 4 16 28 28 310
130 ONLINE 34 34 49 41 34 15 30 49 15 0 12 0 313
45 BOOK 48 56 56 56 56 24 20 0 0 0 0 0 316
37 BOOK 36 84 84 36 24 56 0 0 0 0 0 0 320
110 ONLINE 24 28 28 16 28 28 28 28 28 28 28 28 320
107 ONLINE 32 12 32 50 28 25 33 43 25 27 23 20 350 Moderate (337–672)
71 ONLINE 21 72 61 64 47 50 44 27 0 0 0 0 386
97 ONLINE 48 56 52 40 36 36 32 8 0 36 32 28 404
75 BOOK 36 84 56 56 56 56 0 0 12 28 28 28 440
57 ONLINE 28 56 52 58 52 40 28 28 36 20 28 24 450
170 BOOK 72 84 84 72 72 69 0 0 0 0 0 0 453
134 BOOK 57 63 67 60 60 66 47 44 0 0 0 0 464
39 BOOK 0 0 48 48 48 48 40 56 48 48 48 48 480
94 ONLINE 44 68 54 46 28 32 36 30 36 56 56 56 542
118 ONLINE 64 84 84 84 84 69 63 16 0 0 0 0 548
22 BOOK 48 70 28 28 28 12 0 0 84 84 84 84 550
14 ONLINE 39 55 66 56 59 46 17 25 42 50 53 49 557
186 ONLINE 63 66 60 48 60 54 55 53 46 46 9 0 560
187 BOOK 72 84 84 84 84 76 67 52 8 0 0 0 611
93 ONLINE 0 64 80 84 80 68 53 28 36 36 64 80 673 High (673–1008)
168 ONLINE 0 28 36 84 84 81 63 63 63 63 63 63 691
129 ONLINE 0 24 50 76 80 84 43 38 84 80 84 84 727
20 BOOK 48 84 42 42 84 72 84 84 84 84 84 84 876
182 ONLINE 52 80 84 84 66 60 64 75 79 80 76 84 884
133 ONLINE 64 84 80 80 72 84 60 84 84 84 64 44 884
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mouth in the previous week, the more likely it is he will
have a lower exercise performance level the next week.
However, after correcting for treatment modality (SW-
IMRT vs CSW-IMRT), this significant effect of problems
with mouth opening disappeared (p = 0.16).
Discussion
The key findings of this study are that in HNC patients
treated with SW-IMRT alone or in combination with
chemotherapy [(C)SW-IMRT] adherence to a guided
home-based prophylactic exercise program was high in the
first 6 weeks (70%), but dropped after completion of
treatment. Exercise performance levels during and after
treatment were low especially in patients who were treated
with SW-IMRT in combination with chemotherapy.
Few studies have investigated exercise adherence rates
among HNC patients during treatment. These studies have
yielded inconsistent findings with adherence rates ranging
from 13 to 71% [17, 21, 25, 31–33]. This variety of
adherence percentages may be a matter of definition. In this
study, we used a rather rigid definition of adherence.
Adherence was viewed as a dichotomous outcome with a
pre-specified threshold value. This means for instance that
a patient who was adherent to the program for 6 weeks and
took a break from exercise for a week but continued to
exercise for the next 5 weeks was defined as non-adherent.
Adherence can also be viewed as a categorical or as a
continuous outcome (the total number of exercise per-
formed or the percentage of exercises completed [38]).
According to Huang [39], only percentage of actual exer-
cise activity over an expected exercise activity, or the
number of exercise sessions completed at the prescribed
level divided by the total number of exercise sessions
prescribed, reflects the essence of adherence. However, the
specific timing and the necessary amount of prescribed
prophylactic exercises to obtain any therapeutic benefit are
largely unknown. In the literature, a gap exists for well-
developed measures that capture self-reported adherence to
prescribed but unsupervised home-based exercises [40].
Besides insight into adherence to an intervention, it
is also interesting to have a closer look on how well
patients perform. Our study showed that 40% had a low
6-week exercise performance, while more than half of
participants had a low 12-week performance. In a study
of Mortensen [32] evaluating the impact of home-based
prophylactic swallowing exercises on swallowing-re-
lated outcomes in HNC patients treated with curative
RT, more patients (53%) than in our study had low (5-
week) exercise performance levels. In a retrospective
study of Hutcheson [15], 45% of the adherent patients
performed the prescribed prophylactic exercises more
than four times per day. However, the results of these
studies are difficult to compare because of the various
categorisations of exercise performance level as out-
come measure.
In our study, lower 6- and 12-week exercise perfor-
mance levels were significantly associated with treatment
modality (CSW-IMRT vs SW-IMRT). In addition, we
found a progressively downward trend in prophylactic
exercise performance, indicating that exercise performance








72 BOOK 72 84 84 84 84 75 75 84 84 84 84 84 978
167 BOOK 60 84 84 84 84 84 84 84 84 84 84 84 984
70 ONLINE 72 84 84 84 84 84 84 84 80 84 84 84 992
0 = non-active (does not perform any exercises)
84 = high performance (i.e., four exercise categories three times per day for 7 days)
Fig. 1 Total number of weekly performed exercises by category
(n = 50)
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N (%) N (%) N (%) N (%)




60 (46–76) 62 (40–77) 59 (40–76) 63 (50–77)
Gender 0.74 0.97
Male 15 (38) 24 (62) 21 (54) 18 (46)
Female 5 (45) 6 (55) 6 (54) 5 (46)
Tumour site 0.56 0.64
Oropharynx 13 (43) 17 (57) 17 (57) 13 (43)
Larynx/
Hypopharynx
7 (35) 13 (65) 10 (50) 10 (50)
Tumour stage 1.00 0.69
I/II 3 (43) 4 (57) 3 (43) 4 (57)
III/IV 17 (40) 26 (60) 24 (56) 19 (44)
Treatment 0.015 <0.001
SW-IMRT 5 (22) 18 (78) 6 (26) 17 (74)
CSW-IMRT 15 (56) 12 (44) 21 (78) 6 (22)
HM format 0.42 0.25
Online 9 (35) 17 (65) 12 (46) 14 (54)
Booklet 11 (46) 13 (54) 15 (63) 9 (37)
Coaching sessions 0.18 0.63
Median (range) 5 (3–6) 4 (2–6) 9 (4–12) 9 (4–12)












N = 20 (40%) N = 30 (60%) N = 27 (54%) N = 23 (46%)
Mean (SD) Mean (SD)
Oral pain 26.2 (22.0) 30.3 (28.5) 0.83 27.5 (26.2) 30.1 (26.1) 0.61
Swallowing
problems
17.5 (22.1) 20.8 (24.2) 0.52 19.4 (24.8) 19.6 (21.8) 0.70
Sense problems 7.5 (16.6) 3.9 (12.9) 0.18 7.4 (16.8) 2.9 (10.8) 0.20
Speech problems 16.7 (23.8) 22.6 (26.8) 0.31 16.9 (22.7) 24.1 (28.5) 0.27
Social eating
problems
10.0 (12.8) 14.2 (21.6) 0.83 13.9 (21.2) 10.9 (15.2) 0.75
Social contact
problems
7.3 (10.8) 9.8 (17.6) 0.95 8.4 (14.1) 9.3 (16.5) 0.81
Teeth problems 11.7 (22.4) 22.2 (35.4) 0.38 16.0 (28.3) 20.3 (34.4) 0.81
Mouth opening
problems
5.0 (12.2) 14.4 (31.2) 0.51 9.9 (24.1) 11.6 (27.7) 0.99
Dry mouth 10.0 (15.7) 11.1 (22.0) 0.86 11.1 (22.6) 10.1 (15.7) 0.79
Sticky saliva 20.0 (25.1) 12.2 (23.9) 0.18 21.0 (29.4) 8.7 (15.0) 0.16
Coughing 20.0 (19.9) 18.9 (20.9) 0.80 19.7 (19.1) 18.8 (22.1) 0.75
Feeling ill 11.7 (16.3) 16.7 (24.4) 0.61 13.6 (19.1) 15.9 (24.3) 0.86
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The previous studies showed an increased symptom burden
if chemotherapy was added as treatment modality [5]. HNC
patients undergoing CRT experience several toxicities
which may result in a reduction of the number of pro-
phylactic exercises completed [41].
A limitation of this study was that the study sample
probably consisted of motivated HNC patients who were
committed to exercise and who were motivated to
complete their exercise diaries also. However, we did
not apply a motivational questionnaire, so firm conclu-
sions on the impact of motivation to start exercising
cannot yet be drawn. Study results may not be gener-
alizable to a wider population of HNC patients who may
feel less motivated. In addition, in this study, we chose
to focus on (deterioration of) HNC-specific quality of
life outcomes as possible barriers for exercise perfor-
mance. To evaluate (other) factors possibly associated
with exercise performance levels, larger studies should
be conducted using objective functional outcome mea-
sures in addition to patient-reported outcomes [5, 7],
and psychosocial factors [17]. Furthermore, daily exer-
cise behaviour was self-reported by participants and,
therefore, may be subject to bias. In an attempt to
minimize bias, exercise logs were completed daily. It is
not certain, however, that these instructions were fol-
lowed. The strengths of this study lie in the use of 6-
and 12-week adherence data, and data on levels of
exercise performance. There is growing evidence of the
potential benefits of prophylactic exercises among HNC
patients undergoing (C)RT [21, 23–25, 31], but the
factors associated with adherence to home-based
exercises are largely unknown. Further research is
needed to study predictors to improve adherence, such
as the perception of illness, the perception of ability to
complete therapy, patients’ motivation and intention,
behaviours related to home-based exercises, and social
support and guidance [42].
Conclusion
Adherence of HNC patients to a guided home-based pro-
phylactic exercise program during (C)SW-IMRT was high
during the 6 weeks of treatment, but dropped afterwards.
Exercise performance levels were low especially in
patients who were treated with chemotherapy in combi-
nation with SW-IMRT.
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Table 5 Course of HNC-
specific HRQOL in relation to
weekly exercise performance
level
EORTC-QLQ-H&N35 Current value Lagged value
OR 95% CI p value OR 95% CI p value
Oral pain 1.03 0.94–1.12 0.57 0.93 0.81–1.06 0.26
Swallowing problems 1.07 0.97–1.19 0.19 0.90 0.80–1.01 0.063
Sense problems 1.04 0.92–1.18 0.56 0.94 0.83–1.06 0.31
Speech problems 0.95 0.85–1.07 0.41 0.94 0.84–1.04 0.22
Social eating problems 1.09 0.95–1.24 0.22 0.85 0.71–1.01 0.058
Social contact problems 0.81 0.65–1.02 0.068 1.04 0.89–1.21 0.65
Teeth problems 1.04 0.92–1.17 0.55 0.95 0.86–1.06 0.39
Mouth opening problems 0.95 0.82–1.09 0.43 0.91 0.84–0.99 0.037*
After correcting for treatment 0.96 0.81–1.13 0.59 0.93 0.84–1.03 0.16
Dry mouth 0.97 0.85–1.11 0.70 0.93 0.83–1.03 0.16
Sticky saliva 0.96 0.87–1.07 0.46 0.92 0.81–1.04 0.16
Coughing 1.04 0.95–1.13 0.43 0.91 0.81–1.0 0.080
Feeling ill 0.97 0.87–1.07 0.54 1.00 0.91–1.11 0.99
OR odds ratio for moderate/high-performance level per increase of ten points on the subscale
* p\ 0.05
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